Cambrian Biopharma Revenue and Competitors

Cambrian is a Distributed Drug Discovery Company, or a “DisCo.” We partner with leading academic institutions and start-up companies, providing capital and expertise to advance a portfolio of drug development programs with a shared theme. Each drug in our pipeline has the potential to extend healthy lifespan while treating and preventing multiple age-related diseases, including heart disease, cancer, dementia, metabolic disease, frailty, and many others that have become humanity's leading causes of death in the last century. We collaborate with academic scientists and biotech founders to bring discoveries from the lab to the clinic. We contribute capital for drug discovery and clinical development and take an operational role in creating new medicines partnering with academic scientists, biotech entrepreneurs, and seasoned drug developers.